Literature DB >> 1060094

Hypoxanthine phosphoribosyltransferase deficiency: association of reduced catalytic activity with reduced levels of immunologically detectable enzyme protein.

K S Upchurch, A Leyva, W J Arnold, E W Holmes, W N Kelley.   

Abstract

In the present study hemolysates from fourteen patients with a genetically determined deficiency of hypoxanthine phosphoribosyltransferase (EC 2.4.2.8; IMP:pyrophosphate phosphoribosyltransferase) activity were examined immunologically for the presence of material that crossreacts with the normal enzyme. A quantitative assay for crossreacting material in enzyme-deficient hemolysates was based on the inhibition of the immunoprecipitation of the normal enzyme. As little as 3% of normal crossreacting material could be detected. One patient in this series was found to have a normal amount of crossreacting material, whereas the remainder had no detectable crossreacting protein. The lack of detectable crossreacting material in these patients raises the possibility that a defect in synthesis or degradation of enzyme protein may be present in many patients deficient in hypoxanthine phosphoribosyltransferase.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1060094      PMCID: PMC433155          DOI: 10.1073/pnas.72.10.4142

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  14 in total

1.  A FAMILIAL DISORDER OF URIC ACID METABOLISM AND CENTRAL NERVOUS SYSTEM FUNCTION.

Authors:  M LESCH; W L NYHAN
Journal:  Am J Med       Date:  1964-04       Impact factor: 4.965

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  A specific enzyme defect in gout associated with overproduction of uric acid.

Authors:  W N Kelley; F M Rosenbloom; J F Henderson; J E Seegmiller
Journal:  Proc Natl Acad Sci U S A       Date:  1967-06       Impact factor: 11.205

4.  Selective degradation of abnormal proteins in mammalian tissue culture cells.

Authors:  M R Capecchi; N E Capecchi; S H Hughes; G M Wahl
Journal:  Proc Natl Acad Sci U S A       Date:  1974-12       Impact factor: 11.205

5.  Restoration of hypoxanthine phosphoribosyl transferase activity in mouse 1R cells after fusion with chick-embryo fibroblasts.

Authors:  B Bakay; C M Croce; H Koprowski; W L Nyhan
Journal:  Proc Natl Acad Sci U S A       Date:  1973-07       Impact factor: 11.205

6.  Reappearance of murine hypoxanthine guanine phosphoribosyl transferase activity in mouse A9 cells after attempted hybridisation with human cell lines.

Authors:  B Watson; I P Gormley; S E Gardiner; H J Evans; H Harris
Journal:  Exp Cell Res       Date:  1972-12       Impact factor: 3.905

7.  Mutations affecting the structure of hypoxanthine: guanine phosphoribosyltransferase in cultured Chinese hamster cells.

Authors:  A L Beaudet; D J Roufa; C T Caskey
Journal:  Proc Natl Acad Sci U S A       Date:  1973-02       Impact factor: 11.205

8.  Hypoxanthine-guanine phosphoribosyltransferase: characteristics of the mutant enzyme in erythrocytes from patients with the Lesch-Nyhan syndrome.

Authors:  W J Arnold; J C Meade; W N Kelley
Journal:  J Clin Invest       Date:  1972-07       Impact factor: 14.808

9.  Purification of IMP:pyrophosphate phosphoribosyltransferases, catalytically incompetent enzymes in Lesch-Nyhan disease.

Authors:  C S Rubin; J Dancis; L C Yip; R C Nowinski; M E Balis
Journal:  Proc Natl Acad Sci U S A       Date:  1971-07       Impact factor: 11.205

10.  Lesch-Nyhan syndrome: altered kinetic properties of mutant enzyme.

Authors:  J A McDonald; W N Kelley
Journal:  Science       Date:  1971-02-19       Impact factor: 47.728

View more
  14 in total

1.  Developmental changes in purine phosphoribosyltransferases in human and rat tissues.

Authors:  A Adams; R A Harkness
Journal:  Biochem J       Date:  1976-12-15       Impact factor: 3.857

2.  Intracellular activity of HPRT Cape Town: purine uptake and growth of cultured cells in selective media.

Authors:  L M Steyn; E H Harley
Journal:  J Inherit Metab Dis       Date:  1985       Impact factor: 4.982

3.  Proceedings of a symposium on crystal-related arthropathies. 22 October and 23 October, 1982, Bristol Polytechnic, Bristol.

Authors: 
Journal:  Ann Rheum Dis       Date:  1983-08       Impact factor: 19.103

Review 4.  Human purine metabolism: some recent advances and relationships with immunodeficiency.

Authors:  G Nuki
Journal:  Ann Rheum Dis       Date:  1983-08       Impact factor: 19.103

5.  Immunochemical studies on cultured fibroblasts from patients with inherited methylmalonic acidemia.

Authors:  J F Kolhouse; C Utley; W A Fenton; L E Rosenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1981-12       Impact factor: 11.205

6.  Pathological and immunological observations in a case of Lesch-Nyhan-syndrome.

Authors:  R Bassermann; W Gutensohn; H Jahn; J S Springmann
Journal:  Eur J Pediatr       Date:  1979-10       Impact factor: 3.183

7.  Human hypoxanthine-guanine phosphoribosyltransferase. Demonstration of structural variants in lymphoblastoid cells derived from patients with a deficiency of the enzyme.

Authors:  J M Wilson; B W Baugher; P M Mattes; P E Daddona; W N Kelley
Journal:  J Clin Invest       Date:  1982-03       Impact factor: 14.808

8.  Molecular basis of hypoxanthine-guanine phosphoribosyltransferase deficiency in a patient with the Lesch-Nyhan syndrome.

Authors:  J M Wilson; W N Kelley
Journal:  J Clin Invest       Date:  1983-05       Impact factor: 14.808

9.  Immunochemical studies on cultured fibroblasts from patients with homocystinuria due to cystathionine beta-synthase deficiency.

Authors:  F Skovby; J Kraus; C Redlich; L E Rosenberg
Journal:  Am J Hum Genet       Date:  1982-01       Impact factor: 11.025

10.  Partial hypoxanthine-guanine phosphoribosyl transferase deficiency with full expression of the Lesch-Nyhan syndrome.

Authors:  G Rijksen; G E Staal; M J van der Vlist; F a Beemer; J Troost; W Gutensohn; J P van Laarhoven; C H de Bruyn
Journal:  Hum Genet       Date:  1981       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.